BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3046449)

  • 1. Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease.
    Kalhs P; Panzer S; Kletter K; Minar E; Stain-Kos M; Walter R; Lechner K; Hinterberger W
    Ann Intern Med; 1988 Sep; 109(6):461-4. PubMed ID: 3046449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional asplenia after bone marrow transplantation.
    Kalhs P; Kier P; Lechner K
    Ann Intern Med; 1990 Nov; 113(10):805-6. PubMed ID: 2240887
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional asplenia in patients with chronic graft-versus-host disease: concise communication.
    Al-Eid MA; Tutschka PJ; Wagner HN; Santos GW; Tsan MF
    J Nucl Med; 1983 Dec; 24(12):1123-6. PubMed ID: 6358431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional hyposplenism following allogeneic bone marrow transplantation.
    Cuthbert RJ; Iqbal A; Gates A; Toghill PJ; Russell NH
    J Clin Pathol; 1995 Mar; 48(3):257-9. PubMed ID: 7730489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.
    Duell T; van Lint MT; Ljungman P; Tichelli A; Socié G; Apperley JF; Weiss M; Cohen A; Nekolla E; Kolb HJ
    Ann Intern Med; 1997 Feb; 126(3):184-92. PubMed ID: 9027268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
    Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
    Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
    Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of splenic function after GVHD-associated functional asplenia.
    Demetrakopoulos GE; Tsokos GC; Levine AS
    Am J Hematol; 1982 Feb; 12(1):77-80. PubMed ID: 7039310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
    Rocha V; Wagner JE; Sobocinski KA; Klein JP; Zhang MJ; Horowitz MM; Gluckman E
    N Engl J Med; 2000 Jun; 342(25):1846-54. PubMed ID: 10861319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation corrects the splenic reticuloendothelial dysfunction in sickle cell anemia.
    Ferster A; Bujan W; Corazza F; Devalck C; Fondu P; Toppet M; Verhas M; Sariban E
    Blood; 1993 Feb; 81(4):1102-5. PubMed ID: 8427992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course.
    Clark JG; Crawford SW; Madtes DK; Sullivan KM
    Ann Intern Med; 1989 Sep; 111(5):368-76. PubMed ID: 2669592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group.
    Kolb HJ; Socié G; Duell T; Van Lint MT; Tichelli A; Apperley JF; Nekolla E; Ljungman P; Jacobsen N; van Weel M; Wick R; Weiss M; Prentice HG
    Ann Intern Med; 1999 Nov; 131(10):738-44. PubMed ID: 10577296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The absent and vanishing spleen: congenital asplenia and hyposplenism--two case reports.
    Halbertsma FJ; Neeleman C; Weemaes CM; van Deuren M
    Acta Paediatr; 2005 Mar; 94(3):369-71. PubMed ID: 16028659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional hyposplenia after allogenic bone marrow transplantation: a case report].
    Wollenberg B; Riera-Knorrenschild J; Neubauer A; Görg C
    Ultraschall Med; 2001 Dec; 22(6):289-92. PubMed ID: 11740698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyposplenism after allogeneic bone marrow transplantation.
    Au WY; Ma SK; Wong KK
    Br J Haematol; 2002 Jun; 117(3):488. PubMed ID: 12028014
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversible functional asplenia in chronic aggressive hepatitis.
    Dhawan VM; Spencer RP; Sziklas JJ
    J Nucl Med; 1979 Jan; 20(1):34-6. PubMed ID: 430176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Howell-Jolly body counting as a measure of splenic function. A reassessment.
    Corazza GR; Ginaldi L; Zoli G; Frisoni M; Lalli G; Gasbarrini G; Quaglino D
    Clin Lab Haematol; 1990; 12(3):269-75. PubMed ID: 2125541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.